Data for Cash. 23andMe Sells Parkinson’s Data to Genentech

January 8, 2015 5:14 PM

7 0

Data for Cash. 23andMe Sells Parkinson’s Data to Genentech

Hello profits. Did anyone honestly think 23andMe was going to stick to selling $100 DNA kits? The company is still in regulatory talks with the FDA, but in the meantime has found a sustainable business model. 23andMe announced a $60 million deal with Genentech to provide aggregate genetic data for Parkinson’s research.

On the surface, you may have the reaction of: ‘I can’t believe they are selling medical data.’ That’s understandable, but think of it like this. 23andMe is a small company, backed by Yuri Milner and Google Ventures. All that data would be sitting in storage if they don’t deal or open it up for scien...

Read more

To category page

Loading...